Postnatal steroids in the preterm infant - The good, the ugly, and the unknown

Journal of Pediatrics

Volumn 162, Issue 4, 2013, Pages 667-670

  Inder, Terrie Eleanor ^a,b   Benders, Manon ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE;

BRAIN SIZE; COMPARATIVE STUDY; DISEASE SEVERITY; DRUG HALF LIFE; HUMAN; LUNG DYSPLASIA; META ANALYSIS; POSTNATAL CARE; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT DISEASE; REVIEW; STEROID THERAPY;

EID: 84875434218     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2012.12.039     Document Type: Editorial

References (27)

1. N.A. Parikh, A.K. Kennedy, R.E. Lasky, G.E. McDavid, and J.E. Tyson Pilot randomized trial of hydrocortisone in ventilator-dependent extremely preterm infants: effects on brain volumes J Pediatr 162 2013 685 690
2. W. Onland, M. Offriga, A.P. De Jaegere, and A.H. Kaam Findng the Optimal Postnatal Dexamethasone Regimen for Preterm Infants at Risk of Bronchopulmonary Dysplasia: A Systematic Review of Placebo-Controlled Trials Pediatrics 123 2009 367 377
3. T.F. Yeh, Y.J. Lin, and H.C. Lin Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity N Engl J 350 2004 1304 1313
4. N.A. Parikh, R.E. Lasky, and K.A. Kennedy Postnatal dexamethasone therapy and cerebral tissue volumes in extremely low birth weight infants Pediatrics 119 2007 265 272
5. B.P. Murphy, T.E. Inder, and P.S. Huppi Impaired cerebral cortical gray matter growth after treatment with dexamethasone for neonatal chronic lung disease Pediatrics 107 2001 217 221
6. T.M. O'Shea, J.M. Kothadia, and K.L. Klinepeter Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age Pediatrics 104 1 Pt 1 1999 15 21
7. E.W. Tam, V. Chau, and D.M. Ferriero Preterm cerebellar growth impairment after postnatal exposure to glucocorticoids Sci Transl Med 3 2011 105ra105
8. L.W. Doyle, P.G. Davis, C.J. Morley, A. McPhee, and J.B. Carlin Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter, international, randomized, controlled trial Pediatrics 117 2006 75 83
9. R.S. Sloviter, A.L. Sollas, and S. Neubort Hippocampal dentate granule cell degeneration after adrenalectomy in the rat is not reversed by dexamethasone Brain Res 682 1995 227 230
10. A.H. Hassan, P. von Rosenstiel, V.K. Patchev, F. Holsboer, and O.F. Almeida Exacerbation of apoptosis in the dentate gyrus of the aged rat by dexamethasone and the protective role of corticosterone Exp Neurol 140 1996 43 52
11. D.K. Thompson, S.J. Wood, and L.W. Doyle Neonate hippocampal volumes: prematurity, perinatal predictors, and 2-year outcome Ann Neurol 63 2008 642 651
12. C.C. Huang, H.R. Lin, Y.C. Liang, and K.S. Hsu Effects of neonatal corticosteroid treatment on hippocampal synaptic function Pediatr Res 62 2007 267 270
13. A.W. Meikle, and F.H. Tyler Potency and duration of action of glucocorticoids. Effects of hydrocortisone, prednisone, and dexamethasone on human pituitary-adrenal function Am J Med 63 1977 200 207
14. L.W. Doyle, R.A. Ehrenkranz, and H.L. Halliday Postnatal hydrocortisone for preventing or treating bronchopulmonary dysplasia in preterm infants: a systematic review Neonatology 98 2010 111 117
15. S.E. de Jong, F. Groenendaal, F. van Bel, and K.J. Rademaker Pulmonary effects of neonatal hydrocortisone treatment in ventilator-dependent preterm infants Int J Pediatr 2011 2011 783 893
16. W. Onland, M. Offringa, and F. Cools Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants (the SToP-BPD study); a multicenter randomized placebo controlled trial BMC Pediatr 11 2011 102
17. K.L. Watterberg Policy statement-postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia Pediatrics 126 2010 800 808
18. B.A. Yoder, M. Harrison, and R.H. Clark Time-related changes in steroid use and bronchopulmonary dysplasia in preterm infants Pediatrics 124 2009 673 679
19. M.J. Benders, F. Groenendaal, and F. van Bel Brain development of the preterm neonate after neonatal hydrocortisone treatment for chronic lung disease Pediatr Res 66 2009 555 559
20. M.M. Hitzert, M.J. Benders, A.M. Roescher, F. van Bel, L.S. de Vries, and A.F. Bos Hydrocortisone vs dexamethasone treatment for bronchopulmonary dysplasia and their effects on general movements in preterm infants Pediatr Res 71 2012 100 106
21. K.L. Watterberg, M.L. Shaffer, and M.J. Mishefske Growth and neurodevelopmental outcomes after early low-dose hydrocortisone treatment in extremely low birth weight infants Pediatrics 120 2007 40 48
22. M. van der Heide-Jalving, P.J. Kamphuis, and M.J. van der Laan Short- and long-term effects of neonatal glucocorticoid therapy: is hydrocortisone an alternative to dexamethasone? Acta Paediatr 92 2003 827 835
23. G.A. Lodygensky, K. Rademaker, and S. Zimine Structural and functional brain development after hydrocortisone treatment for neonatal chronic lung disease Pediatrics 116 2005 1 7
24. K.J. Rademaker, C.S. Uiterwaal, and F. Groenendaal Neonatal hydrocortisone treatment: neurodevelopmental outcome and MRI at school age in preterm-born children J Pediatr 150 2007 351 357
25. R. Karemaker, C.J. Heijnen, and S. Veen Differences in behavioral outcome and motor development at school age after neonatal treatment for chronic lung disease with dexamethasone versus hydrocortisone Pediatr Res 60 2006 745 750
26. K.J. Rademaker, M. Rijpert, and C.S. Uiterwaal Neonatal hydrocortisone treatment related to 1H-MRS of the hippocampus and short-term memory at school age in preterm born children Pediatr Res 59 2006 309 313
27. M. Ter Wolbeek, L.M. de Sonneville, and W.B. de Vries Early life intervention with glucocorticoids has negative effects on motor development and neuropsychological function in 14-17year-old adolescents Psychoneuroendocrinology 2012 In press